AfroCentric posts mixed annual results with a 74.9% profit drop due to impairments, but higher headline earnings signal a recovery in SA’s pharmaceutical sector.
AfroCentric reports mixed results amid strategic investments
Original Article by Jacob Webster | Business Day | 3 September 2024
AfroCentric posts mixed annual results with a 74.9% profit drop due to impairments, but higher headline earnings signal a recovery in SA's pharmaceutical sector.